Tali Lanton, Ph.D.

Senior Client Strategist

An integral member of FreeMind’s client strategy team, Tali is keen to learn about new and exciting research goals of companies, in order to identify and recommend all relevant non-dilutive funding opportunities. Tali’s aim is to strategize a long term submission plan to facilitate support from U.S. federal agencies in the form of scientific review and recognition, as well as non-dilutive funding potential.

Tali began her journey in the life sciences at McGill University, in Montreal, Canada, where she graduated with distinction as a BSc. in Biology. She then continued her studies for both a Master’s and PhD in the fields of genetics, cancer, inflammation, hepatology, and metabolic syndrome, employing cytokine manipulation techniques at the Hebrew University. Her post-doctorate studies at the Hebrew University focused on RNA-RNA hybrid predictive strategies to target key oncogenes in pancreatic cancer. Tali’s expertise in scientific research study design and her robust academic background, make her an asset to FreeMind’s clients.